FDA — authorised 20 December 2002
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: approved
🇺🇸 Extraneal in United States
FDA authorised Extraneal on 20 December 2002
Marketing authorisations
FDA — authorised 20 December 2002
- Application: NDA021321
- Marketing authorisation holder: VANTIVE US HLTHCARE
- Indication: Type 1 - New Molecular Entity
- Status: approved
Extraneal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Extraneal approved in United States?
Yes. FDA authorised it on 20 December 2002; FDA authorised it on 20 December 2002.
Who is the marketing authorisation holder for Extraneal in United States?
BAXTER HLTHCARE holds the US marketing authorisation.